| Ansøgningsnr. og dato | 18867097.0 (espacenet) (Federated) (European Patent Register), 20181012 | | Patent/reg.nr. og dato | DK/EP 3679141, 20230607 | | Tilgængelighedsdato | 20200715 | | Prioritetsnr. og dato | US 201762572398 P, 20171013, US 201762572403 P, 20171013, US 201862726950 P, 20180904 | | EP publ. nr. og dato |
EP 3679141 20200715 | | Løbedag | | | Ansøger/indehaver | Novo Nordisk Health Care AG,
The Circle 32/38
8058 Zürich, CH | | Ansøgers ref. nr. | | | Opfinder | BROWN, Bob, D., c/o Dicerna Pharmaceuticals, Inc.
33, Hayden Avenue
Lexington, MA 02421, US,
DUDEK, Henryk, T., c/o Dicerna Pharmaceuticals, Inc.
33, Hayden Avenue
Lexington, MA 02421, US,
SAXENA, Utsav, c/o Dicerna Pharmaceuticals, Inc.
33, Hayden Avenue
Lexington, MA 02421, US,
PURSELL, Natalie, c/o Dicerna Pharmaceuticals, Inc.
33, Hayden Avenue
Lexington, MA 02421, US,
LAI, Cheng, c/o Dicerna Pharmaceuticals, Inc.
33, Hayden Avenue
Lexington, MA 02421, US,
WANG, Weimin, c/o Dicerna Pharmaceuticals, Inc.
33, Hayden Avenue
Lexington, MA 02421, US,
STORR, Rachel, c/o Dicerna Pharmaceuticals, Inc.
33, Hayden Avenue
Lexington, MA 02421, US,
NAZEF, Naim, c/o Dicerna Pharmaceuticals, Inc.
33, Hayden Avenue
Lexington, MA 02421, US,
KIM, Boyoung, c/o Dicerna Pharmaceuticals, Inc.
33, Hayden Avenue
Lexington, MA 02421, US | | Fuldmægtig | | | Interessent på tilknyttet sag | | | IPC-Klasse | A61K 31/713 (2006.01) , C12N 15/113 (2010.01) | | Titel/benævnelse | METHODS AND COMPOSITIONS FOR INHIBITING EXPRESSION OF LDHA | | Internationalt ansøgningsnr. | US2018055735 | | Internationalt publ. nr. | WO2019075419 | | Relateret sag (certifikat) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
